Ghent University Academic Bibliography

Your filters: cql: author="Jankowski, Joachim" or (type any "bookEditor issueEditor" and editor="Jankowski, Joachim")

Add to list
A guide to uraemic toxicity

Griet Glorieux (UGent) , Stephane Burtey, Pieter Evenepoel, Joachim Jankowski, Laetitia Koppe, Rosalinde Masereeuw and Raymond Vanholder (UGent)

(2026) NATURE REVIEWS NEPHROLOGY. 22(1). p.50-68
Add to list
- Journal Article
- A1
- open access
The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney : a systematic review

Shruti Bhargava, Zhuangting Rao, Raymond Vanholder (UGent) , Frank Tacke, Heidi Noels, Vera Jankowski, Juliane Hermann and Joachim Jankowski

(2026) MOLECULAR METABOLISM. 103.
Add to list
- Journal Article
- A2
- open access
Metabolomics to identify unclassified uremic toxins : a comprehensive literature review

Raymond Vanholder (UGent) , Griet Glorieux (UGent) , Angel Argiles, Stephane Burtey, Gerald Cohen, Flore Duranton, Laetitia Koppe, Ziad A. Massy, Alberto Ortiz, Rosalinde Masereeuw, et al.

(2025) KIDNEY MEDICINE. 7(3).
Add to list
- Journal Article
- A1
- open access
A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)

Raymond Vanholder (UGent) , Angel Argiles and Joachim Jankowski

(2021) CLINICAL KIDNEY JOURNAL. 14(6). p.1514-1523
Add to list
Lipoproteins and fatty acids in chronic kidney disease : molecular and metabolic alterations

Heidi Noels, Michael Lehrke, Raymond Vanholder (UGent) and Joachim Jankowski

(2021) NATURE REVIEWS NEPHROLOGY. 17(8). p.528-542
Add to list
- Journal Article
- A1
- open access
Data sharing under the General Data Protection Regulation : time to harmonize law and research ethics?

Antonia Vlahou, Dara Hallinan, Rolf Apweiler, Angel Argiles, Joachim Beige, Ariela Benigni, Rainer Bischoff, Peter C. Black, Franziska Boehm, Jocelyn Ceraline, et al.

(2021) HYPERTENSION. 77(4). p.1029-1035
Add to list
- Journal Article
- A1
- open access
An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances

Tino Vollmer, Borje Ljungberg, Vera Jankowski, Joachim Jankowski, Griet Glorieux (UGent) and Bernd G Stegmayr

(2019) SCIENTIFIC REPORTS. 9.
Add to list
A urinary proteome-based classifier for the early detection of decline in glomerular filtration

Claudia Pontillo, Lotte Jacobs, Jan A Staessen, Joost P Schanstra, Peter Rossing, Hiddo JL Heerspink, Justyna Siwy, William Mullen, Antonia Vlahou, Harald Mischak, et al.

(2017) NEPHROLOGY DIALYSIS TRANSPLANTATION. 32(9). p.1510-1516
Add to list
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis

Justyna Siwy, Petra Zürbig, Angel Argiles, Joachim Beige, Marion Haubitz, Joachim Jankowski, Bruce A Julian, Peter G Linde, David Marx, Harald Mischak, et al.

(2017) NEPHROLOGY DIALYSIS TRANSPLANTATION. 32(12). p.2079-2089
Add to list
- Journal Article
- A1
- open access
Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker

Claudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, Lotte Jacobs, Petra Zürbig, Lutgarde Thijs, Adela Ramirez-Torrez, Hiddo JL Heerspink, Morten Lindhardt, Ronald Klein, et al.

(2017) KIDNEY INTERNATIONAL REPORTS. 2(6). p.1066-1075

Academic Bibliography

A guide to uraemic toxicity

The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney : a systematic review

Metabolomics to identify unclassified uremic toxins : a comprehensive literature review

A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)

Lipoproteins and fatty acids in chronic kidney disease : molecular and metabolic alterations

Data sharing under the General Data Protection Regulation : time to harmonize law and research ethics?

An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances

A urinary proteome-based classifier for the early detection of decline in glomerular filtration

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis

Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker

Contents

Support

Contact